OR7-8: A phase II randomised, open-label, parallelgroup...

Growth Hormone & IGF Research 2014 / 10 Vol. 24

OR7-8: A phase II randomised, open-label, parallelgroup study of the safety, tolerability, pharmacokinetics and efficacy of two subcutaneous dosing regimens of ATL1103 in adult patients with acromegaly

Trainer, P.J., Newell-Price, J., Ayuk, J., Aylwin, S., Drake, W.M., Rees, A., Chanson, P., Brue, T., Webb, S.M., Fajardo, C., Aller, J., McCormack, A., Torpy, D.J., Tachas, G., Atley, L.M., Bidlingmai
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
24
Language:
english
Journal:
Growth Hormone & IGF Research
DOI:
10.1016/S1096-6374(14)50054-8
Date:
October, 2014
File:
PDF, 449 KB
english, 2014
Conversion to is in progress
Conversion to is failed